Neural progenitor cell differentiation

Patent metadata

Field	Value
Publication number	US-9862924-B2
Application number	US-201414777335-A
Country	US
Kind code	B2
Filing date	Mar 17, 2014
Priority date	Mar 15, 2013
Publication date	Jan 9, 2018
Grant date	Jan 9, 2018

Abstract

Differentiation and stability of neural stem cells can be enhanced by in vitro or in vivo culturing with one or more extracellular matrix (ECM) compositions, such as collagen I, IV, laminin and/or a heparan sulfate proteoglycan. In one aspect of the invention, adult mammalian enteric neuronal progenitor cells can be induced to differentiate on various substrates derived from components or combinations of neural ECM compositions. Collagen I and IV supported neuronal differentiation and extensive glial differentiation individually and in combination. Addition of laminin or heparan sulfate to collagen substrates unexpectedly improved neuronal differentiation, increasing neuron number, branching of neuronal processes, and initiation of neuronal network formation. In another aspect, neuronal subtype differentiation was affected by varying ECM compositions in hydrogels overlaid on intestinal smooth muscle sheets. The matrix compositions of the present invention can be used to tissue engineer transplantable innervated GI smooth muscle constructs to remedy aganglionic disorders.

First claim

The invention claimed is:

1. A method of biasing neural stem cell differentiation in vitro into differentiated neural cells that are enriched for cholinergic neurons, the method comprising:
obtaining a population of longitudinal smooth muscle cells;
culturing the longitudinal smooth muscle cells to form a uniaxially-aligned smooth muscle sheet;
obtaining a population of neural stem cells;
culturing the neural stem cells in a hydrogel that contains at least one extracellular matrix (ECM) component, wherein the hydrogel is applied to the uniaxially-aligned smooth muscle sheet; and
exposing the neural stem cells to the at least one ECM component in the hydrogel, wherein the ECM component comprises collagen I and biases differentiation of the neural stem cells into differentiated neural cells that are enriched for cholinergic neurons.

2. The method of claim 1 , wherein the hydrogel comprises at least about 800 μg/ml collagen I.

3. The method of claim 1 , wherein the hydrogel comprises between about 800 μg/ml and about 1600 μg/ml collagen I.

4. The method of claim 1 , further comprising isolating the differentiated neural cells and administering the differentiated neural cells to a patient.

5. The method of claim 4 , wherein the administering comprises injecting the differentiated neural cells in the hydrogel into the patient.

6. The method of claim 1 , wherein the differentiated neural cells innervate the uniaxially-aligned smooth muscle sheet to form an innervated smooth muscle sheet.

7. The method of claim 6 , further comprising implanting the innervated smooth muscle sheet into a patient.

8. A method of biasing neural stem cell differentiation in vitro into differentiated neural cells that are enriched for nitrergic neurons, the method comprising
obtaining a population of longitudinal smooth muscle cells;
culturing the longitudinal smooth muscle cells to form a uniaxially-aligned smooth muscle sheet;
obtaining a population of neural stem cells;
culturing the neural stem cells that contains at least one extracellular matrix (ECM) component in a hydrogel, wherein the hydrogel is applied to the uniaxially-aligned smooth muscle sheet; and
exposing the neural stem cells to the at least one ECM component in the hydrogel, wherein the ECM component comprises collagen IV and is substantially free of laminin and biases differentiation of the neural stem cells into differentiated neural cells that are enriched for nitrergic neurons.

9. The method of claim 8 , wherein the hydrogel comprises at least about 200 μg/ml collagen IV and is substantially free of laminin.

10. A method of biasing neural stem cell differentiation in vitro into differentiated neural cells that are enriched for peptidergic neurons, the method comprising
obtaining a population of longitudinal smooth muscle cells;
culturing the longitudinal smooth muscle cells to form a uniaxially-aligned smooth muscle sheet;
obtaining a population of neural stem cells;
culturing the neural stem cells that contains at least one extracellular matrix (ECM) component in a hydrogel, wherein the hydrogel is applied to the uniaxially-aligned smooth muscle sheet; and
exposing the neural stem cells to the at least one ECM component in the hydrogel, wherein the ECM component comprises collagen I, collagen IV, and laminin and biases differentiation of the neural stem cells into differentiated neural cells that are enriched for peptidergic neurons.

11. The method of claim 10 , wherein the hydrogel comprises at least about 800 μg/ml collagen I, at least about 200 μg/ml collagen IV, and at least about 5 μg/ml laminin.

12. A method of biasing neural stem cell differentiation in vitro in a uniaxially-aligned smooth muscle sheet construct, comprising:
obtaining a population of neural stem cells;
obtaining a population of longitudinal smooth muscle cells;
culturing the longitudinal smooth muscle cells on a surface having an orienting microtopography to obtain a uniaxially-aligned smooth muscle cell sheet; and
culturing the neural stem cells in the presence of the longitudinal smooth muscle cell sheet, wherein the neural stem cells are adhered to a substrate with a substrate-coating that contains at least one extracellular matrix (ECM) component, wherein the substrate-coating comprises at least one of laminin, collagen I, and collagen IV, and wherein the ECM component biases differentiation of the neural stem cells into differentiated neural cells that are enriched for neurons.

13. The method of claim 12 , wherein the substrate-coating comprises laminin, and at least one of collagen I and collagen IV.

14. The method of claim 12 , wherein the substrate-coating comprises collagen I and collagen IV, and at least one of laminin and heparan sulfate.

15. The method of claim 12 , further comprising isolating the differentiated neural cells and administering the differentiated neural cells to a patient.

16. The method of claim 15 , wherein the administering comprises injecting the differentiated neural cells into the patient.

17. A method of biasing neural stem cell differentiation in vitro in a uniaxially-aligned smooth muscle sheet construct, comprising:
obtaining a population of neural stem cells;
obtaining a population of longitudinal smooth muscle cells;
culturing the longitudinal smooth muscle cells on a surface having an orienting microtopography to obtain a uniaxially-aligned smooth muscle cell sheet; and
culturing the neural stem cells in the presence of the smooth muscle cells, wherein the neural stem cells are adhered to a substrate with a substrate-coating that contains at least one extracellular matrix (ECM) component, wherein the substrate-coating comprises at least one of collagen I and collagen IV, and wherein the ECM component biases differentiation of the neural cells into differentiated neural cells that are enriched for glial cells.

18. The method of claim 17 , wherein the substrate-coating comprises at least collagen I and collagen IV, and is substantially free of at least one of laminin and heparan sulfate.

19. The method of claim 17 , wherein the substrate-coating comprises at least 5 μg/cm 2 collagen I and at least 5 μg/cm 2 collagen IV, and is substantially free of at least one of laminin and heparan sulfate.

20. The method of claim 17 , further comprising isolating the differentiated neural cells and administering the differentiated neural cells to a patient.

21. The method of claim 20 , wherein the administering comprises injecting the differentiated neural cells into the patient.

Assignees

• Univ Wake Forest Health Sciences

Inventors

• Bitar Khalil

Classifications

• C12N2502/1347

  Smooth muscle cells · CPC title

• A61K35/34

  Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes (vascular smooth muscle A61K35/44) · CPC title

• C12N5/0622

  Glial cells, e.g. astrocytes, oligodendrocytes; Schwann cells · CPC title

• C12N2533/90

  Substrates of biological origin, e.g. extracellular matrix, decellularised tissue · CPC title

• C12N2533/52

  Fibronectin; Laminin · CPC title